• Profile
Close

Assessment and treatment outcomes of persistent radiation-induced alopecia in patients with cancer

JAMA Sep 15, 2020

Phillips GS, Freret ME, Friedman DN, et al. - Researchers sought to report on the clinical features, associated factors, and treatment response of Persistent radiation-induced alopecia (pRIA) in patients with primary central nervous system (CNS) tumors or head and neck sarcoma. At 2 large tertiary care hospitals and comprehensive cancer centers, they conducted a retrospective cohort study of 71 children and adults diagnosed with primary CNS tumors or head and neck sarcomas evaluating pRIA. The patients showed localized, diffuse, or mixed patterns of alopecia with frequent white patches on trichoscopy. They observed severe alopecia in association with greater scalp radiation dose and proton irradiation. Improvement in alopecia was noted in 82% of patients treated with topical minoxidil, 5%, solution and 100% of patients managed surgically. This suggests topical minoxidil as effective in improving alopecia observed in most cases with persistent radiation-induced alopecia, and surgical procedures as possibly effective in nonresponders.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay